{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T03:56:36Z","timestamp":1774151796107,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.lfs.2022.120843","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T23:24:14Z","timestamp":1659137054000},"page":"120843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Repurposing clofazimine for malignant pleural mesothelioma treatment \u2014 In-vitro assessment of efficacy and mechanism of action"],"prefix":"10.1016","volume":"306","author":[{"given":"Vineela","family":"Parvathaneni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rameswari","family":"Chilamakuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuechun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120843_bb0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1183\/16000617.0063-2016","article-title":"Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment","volume":"25","author":"Bibby","year":"2016","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.lfs.2022.120843_bb0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00319-2017","article-title":"Malignant pleural mesothelioma: new treatments, new hopes?","volume":"49","author":"Scherpereel","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2022.120843_bb0015","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1186\/s12885-021-08913-2","article-title":"Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden","volume":"21","author":"Hemminki","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2022.120843_bb0020","article-title":"Malignant pleural mesothelioma epidemiology in the United States from 2000 to 2016","volume":"13","author":"Thomas","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.lfs.2022.120843_bb0025","first-page":"1433","article-title":"Malignant mesothelioma","volume":"29","author":"Ahmed","year":"2013","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.lfs.2022.120843_bb0030","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk","year":"2013","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lfs.2022.120843_bb0035","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.lfs.2022.120843_bb0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2022.120843_bb0045","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0098-2017","article-title":"Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?","volume":"27","author":"Boyer","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.lfs.2022.120843_bb0050","series-title":"FDA Approves Nivolumab and Ipilimumab for Unresectable Malignant Pleural Mesothelioma","year":"2021"},{"key":"10.1016\/j.lfs.2022.120843_bb0055","article-title":"Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma","author":"Dell\u2019Anno","year":"2020","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.lfs.2022.120843_bb0060","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2022.120843_bb0065","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.3390\/ijms21176306","article-title":"Repurposing quinacrine for treatment of malignant mesothelioma: in-vitro therapeutic and mechanistic evaluation","volume":"21","author":"Kulkarni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120843_bb0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bcp.2013.12.007","article-title":"Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical wnt signaling","volume":"87","author":"Koval","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120843_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.leukres.2017.01.019","article-title":"Anti-cancer effect of clofazimine as a single agent and in combination with cisplatin on U266 multiple myeloma cell line","volume":"55","author":"Durusu","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.lfs.2022.120843_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.602817","article-title":"Beyond TNBC: repositioning of clofazimine against a broad range of wnt-dependent cancers","volume":"10","author":"Xu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2022.120843_bb0085","series-title":"The Potential of an Old Drug to Fight Cancer","year":"2021"},{"key":"10.1016\/j.lfs.2022.120843_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2019.02.018","article-title":"Towards the first targeted therapy for triple-negative breast cancer: repositioning of clofazimine as a chemotherapy-compatible selective wnt pathway inhibitor","volume":"449","author":"Ahmed","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2022.120843_bb0095","first-page":"4547","article-title":"Wnt pathway activation in mesothelioma: evidence of dishevelled overexpression and transcriptional activity of \u03b2-Catenin1","volume":"63","author":"Uematsu","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2022.120843_bb0100","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.3390\/ijms21239107","article-title":"The crosstalk between FAK and wnt signaling pathways in cancer and its therapeutic implication","volume":"21","author":"W\u00f6rthm\u00fcller","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120843_bb0105","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/1535-7163.MCT-15-0532","article-title":"Recombinant immunotoxin with T-cell epitope mutations that greatly reduce immunogenicity for treatment of mesothelin-expressing tumors","volume":"14","author":"Mazor","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2022.120843_bb0110","doi-asserted-by":"crossref","first-page":"29916","DOI":"10.18632\/oncotarget.9171","article-title":"Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity","volume":"7","author":"Mazor","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2022.120843_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11095-020-02848-2","article-title":"Nanotechnology based repositioning of an anti-viral drug for non-small cell lung cancer (NSCLC)","volume":"37","author":"Parvathaneni","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2022.120843_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101144","article-title":"Migration rate inhibition of breast cancer cells treated by caffeic acid and caffeic acid phenethyl Ester: an in vitro comparison study","volume":"9","author":"Kaba\u0142a-Dzik","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2022.120843_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111139","article-title":"Development of pharmaceutically scalable inhaled anti-cancer nanotherapy \u2013 repurposing amodiaquine for non-small cell lung cancer (NSCLC)","volume":"115","author":"Parvathaneni","year":"2020","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.lfs.2022.120843_bb0130","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.7150\/ijbs.13453","article-title":"Blockage of epithelial to mesenchymal transition and upregulation of let 7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell","volume":"12","author":"Sohn","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2022.120843_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054072","article-title":"OpenCFU, a new free and open-source software to count cell colonies and other circular objects","volume":"8","author":"Geissmann","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.lfs.2022.120843_bb0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/bit.26845","article-title":"3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs","volume":"116","author":"Nunes","year":"2019","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.lfs.2022.120843_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijbiomac.2020.05.146","article-title":"Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma \u2013 a rare thoracic cancer","volume":"160","author":"Shukla","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2022.120843_bb0150","doi-asserted-by":"crossref","first-page":"24018","DOI":"10.18632\/oncotarget.8116","article-title":"Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma","volume":"7","author":"Agarwal","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2022.120843_bb0155","first-page":"1327","article-title":"Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas","volume":"24","author":"Li","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2022.120843_bb0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.lfs.2022.120843_bb0165","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1016\/j.jtcvs.2017.12.131","article-title":"Macroscopic complete resection is not associated with improved survival in patients with malignant pleural mesothelioma","volume":"155","author":"Batirel","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lfs.2022.120843_bb0170","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jtho.2018.08.001","article-title":"Surgery in malignant pleural mesothelioma","volume":"13","author":"Bueno","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lfs.2022.120843_bb0175","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","article-title":"A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"122","author":"Rusch","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lfs.2022.120843_bb0180","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/ejcts\/ezv398","article-title":"Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma","volume":"49","author":"Kostron","year":"2016","journal-title":"Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg."},{"key":"10.1016\/j.lfs.2022.120843_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/fon.15.312","article-title":"Management of recurrence after initial surgery for malignant pleural mesothelioma: a mini-review","volume":"11","author":"Halezero\u011flu","year":"2015","journal-title":"Future Oncol. Lond. Engl."},{"key":"10.1016\/j.lfs.2022.120843_bb0190","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijbiomac.2018.10.181","article-title":"Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer","volume":"122","author":"Vaidya","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2022.120843_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4939-7401-6_8","article-title":"In vitro tumorigenic assay: Colony forming assay for cancer stem cells","volume":"1692","author":"Rajendran","year":"2018","journal-title":"Methods Mol. Biol. Clifton NJ."},{"key":"10.1016\/j.lfs.2022.120843_bb0200","article-title":"Comparison of the proliferative and clonogenic growth capacity of wound fluid from breast cancer patients treated with and without intraoperative radiotherapy","volume":"4","author":"Veldwijk","year":"2015","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.lfs.2022.120843_bb0205","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/pharmaceutics11110559","article-title":"Metformin-encapsulated liposome delivery system: an effective treatment approach against breast cancer","volume":"11","author":"Shukla","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2022.120843_bb0210","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1002\/jcp.26579","article-title":"Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: a pre-clinical assessment","volume":"233","author":"Barbarino","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2022.120843_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101446","article-title":"In vitro characterization of cisplatin and pemetrexed effects in malignant pleural mesothelioma 3D culture phenotypes","volume":"11","author":"Papazoglou","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2022.120843_bb0220","first-page":"102","article-title":"Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids","volume":"36","author":"Riffle","year":"2017","journal-title":"J. Exp. Clin. Cancer Res. CR."},{"key":"10.1016\/j.lfs.2022.120843_bb0225","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/abbs\/gmx089","article-title":"Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt\/\u03b2-catenin pathway","volume":"49","author":"Zheng","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.lfs.2022.120843_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-018-2108-x","article-title":"Gigantol inhibits Wnt\/\u03b2-catenin signaling and exhibits anticancer activity in breast cancer cells","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.lfs.2022.120843_bb0235","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12885-018-4385-7","article-title":"Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter","volume":"18","author":"Blum","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2022.120843_bb0240","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1158\/1078-0432.CCR-07-0161","article-title":"A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo","volume":"13","author":"Gills","year":"2007","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.lfs.2022.120843_bb0245","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.3390\/ijms15035045","article-title":"A caspase-dependent pathway is involved in Wnt\/\u03b2-catenin signaling promoted apoptosis in bacillus calmette-guerin infected RAW264.7 macrophages","volume":"15","author":"Wu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120843_bb0250","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1080\/15548627.2016.1173799","article-title":"Autophagy initiation correlates with the autophagic flux in 3D models of mesothelioma and with patient outcome","volume":"12","author":"Follo","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2022.120843_bb0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mc.22757","article-title":"Inhibition of autophagy initiation potentiates chemosensitivity in mesothelioma","volume":"57","author":"Follo","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lfs.2022.120843_bb0260","doi-asserted-by":"crossref","first-page":"29482","DOI":"10.18632\/oncotarget.5022","article-title":"Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells","volume":"6","author":"Hwang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2022.120843_bb0265","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1021\/acs.bioconjchem.7b00165","article-title":"Comparison of tumor penetration of podophyllotoxin-carboxymethylcellulose conjugates with various chemical compositions in tumor spheroid culture and in vivo solid tumor","volume":"28","author":"Yang","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.lfs.2022.120843_bb0270","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1039\/C7PY00559H","article-title":"Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines","volume":"8","author":"Lazzari","year":"2017","journal-title":"Polym. Chem."},{"key":"10.1016\/j.lfs.2022.120843_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-020-0973-6","article-title":"Cells grown in three-dimensional spheroids mirror in vivo metabolic response of epithelial cells","volume":"3","author":"Lagies","year":"2020","journal-title":"Commun. Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522005434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522005434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:05:38Z","timestamp":1758402338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522005434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":55,"alternative-id":["S0024320522005434"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120843","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing clofazimine for malignant pleural mesothelioma treatment \u2014 In-vitro assessment of efficacy and mechanism of action","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120843"}}